Skip to main content

Mark Podberezin, MD, PhD

Anatomic Pathologist

Board Certifications

Hematology, Anatomic and Clinical Pathology

Fellowship

Hematopathology, Surgical Pathology

Locations

Hematopathology, Surgical Pathology, ProPath

Biography

  • Residency - Anatomic and Clinical Pathology, University of Illinois at Chicago, Chicago, IL
  • Medical School - Tver State Medical Academy, Tver, Russia
  • Joined ProPath: 2023

 

Peer-Reviewed Articles

  1. Puchalski A, Willett J, Podberezin M, D'Silva K, Yarlagadda B, Restrepo A. Stage IV Hodgkin's lymphoma with primary presentation as a large thyroid mass. Clin Thyroidol. 2021 Apr 8;33(4):187-193.

  2. Podberezin M, Fitzpatrick MJ, Hariri LP, Sholl L. Malignant peritoneal mesothelioma presenting as a splenic mass. Pathol Res Pract. 2020 Dec;216(12):153273.

  3. Podberezin M, Sohani AR. CD30-positive lymphomatous (nonleukemic) variant of adult T-cell leukemia/lymphoma, HTLV-1 associated. Clin Case Rep. 2020 Jul 20;8(12):2395-2397.

  4. Baniak N, Podberezin M, Kanthan S, Kanthan R. Primary pulmonary/pleural melanoma in a 13 year-old presenting as pleural effusion. Pathol Res Pract. 2017;213(2):161-164.

  5. Elshoni H, Stakiw J, Podberezin M. Case study of intracerebral recurrence of plasmablastic myeloma with achievement of complete response after treatment with thalidomide. Advances in Cytology & Pathology. 2017;2(3):1-3.

  6. Podberezin M, Wen J, Chang CC. Cancer stem cells: a review of potential clinical applications. Arch Pathol Lab Med. 2013 Aug;137(8):1111-6.

  7. Podberezin M. A thirty-nine -year-old woman with an abdominal mass. Scripta Medica. 2011;42(1).

  8. Podberezin M, Meriggioli MN, Locante A, Voros A, Valyi-Nagy T, Kajdacsy-Balla A. Hashimoto encephalopathy with fulminant myocarditis. Pathol Res Pract. 2010 Oct 15;206(10):720-2.

  9. Podberezin M, Angeles R, Guzman G, Peace D, Gaitonde S. Primary pancreatic sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): an unusual extranodal manifestation clinically simulating malignancy. Arch Pathol Lab Med. 2010 Feb;134(2):276-8.

  10. Podberezin M, Angeles R, Peace D, Rondelli D, Quigley J, Lindgren V, Gaitonde S. Acute myeloid leukemia with myelodysplasia-related changes: a new entity defined by the WHO 2008 Classification of Hematopoietic and Lymphoid Neoplasms. Laboratory Medicine. 2009;40(7):397-400.

  11. Boles RG, Chaudhari D, Söderkvist J, Podberezin M, Ito M. Quantification of mitochondrial DNA heteroplasmy by temporal temperature gradient gel electrophoresis. Clin Chem. 2003 Jan;49(1):198-200.

  12. Podberezin M, Levina A, Romanova L, Margolin O, Nasibov O, Pivnik AV. Quantitation of red cell-bound immunoglobulins and complement in lymphoma patients. Immunohematology. 2000;16(4):147-53.

 

Abstracts

  1. Podberezin M. Autoimmune myelofibrosis [case presentation]. Bone marrow workshop. European Association of Hematopathology-Society for Hematopathology Annual Meeting, 2021.

  2. Podberezin M, Kadkol S, Wiley E, Guzman G. Evaluation of microsatellite instability in mucoepidermoid carcinoma [poster 17]. Arch Pathol Lab Med. 2009;133(10):1704.

  3. Podberezin M, Sriprasart T, De Guzman E, Mehendale S, August C. Cardiac epithelioid angiosarcoma with pulmonary metastases presenting as primary pulmonary epithelioid hemangioendothelioma [poster 68]. Arch Pathol Lab Med. 2009;133(10):1699-1700.

  4. Podberezin M, Metelitsa LS, Shimada H, Seeger RC. The role of GPI-linked molecules in neutrophil-mediated ADCC against neuroblastoma cells. Proceedings of the annual meeting of American Association for Cancer Research, New Orleans, LA, 2001.

  5. Podberezin M, Metelitsa LS, Gillies S, Super M, Keshelava N, Seeger RC. Neutrophil ADCC with a humanized anti-GD2/GM-CSF immunocytokine against different neuroblastoma cell lines. Proceedings of the annual meeting of American Association for Cancer Research, San Francisco, CA, 2000.

  6. Podberezin M, de Giorgi L, Booker DJ, Stamps R, Sokol RJ. Evaluation of red cell autoantibodies in patients with primary and secondary autoimmune haemolysis using a chemiluminiscence test. Transfusion Medicine. 1996;6:23.

  7. De Giorgi L, Podberezin M, Booker DJ, Stamps R, Sokol RJ. A chemiluminiscence test for predicting the severity of autoimmune hemolysis. Transfusion Medicine. 1996;6:23.
Previous
Next